Biora submits updated IND application for ulcerative colitis drug/device trial

cafead

Administrator
Staff member
  • cafead   Oct 24, 2023 at 09:52: AM
via Biora Therapeutics has submitted an updated investigational new drug (IND) application with the US Food and Drug Administration (FDA) for further development of the company’s drug/device combination, BT-600.

article source